BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37286868)

  • 1. Nrf2/HO-1 Alleviates Disulfiram/Copper-Induced Ferroptosis in Oral Squamous Cell Carcinoma.
    Zhao Y; Zhu S
    Biochem Genet; 2024 Feb; 62(1):144-155. PubMed ID: 37286868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disulfiram/Copper Activates ER Stress to Promote Immunogenic Cell Death of Oral Squamous Cell Carcinoma.
    Zhao Y; Zhao B; Zhu S
    Cell Biochem Biophys; 2024 May; ():. PubMed ID: 38727783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lung adenocarcinoma by combinations of sulfasalazine (SAS) and disulfiram-copper (DSF-Cu) in cell line models and mice.
    Bagherpoor AJ; Shameem M; Luo X; Seelig D; Kassie F
    Carcinogenesis; 2023 Jun; 44(4):291-303. PubMed ID: 37053033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Acid-Responsive Iron-Based Nanocomposite for OSCC Treatment.
    Zhao X; Leng D; Wang H; Jin H; Wu Y; Qin Z; Wu D; Wei X
    J Dent Res; 2024 Jun; 103(6):612-621. PubMed ID: 38684484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment with ferroptosis and autophagy inducers significantly inhibit the proliferation and migration of oral squamous cell carcinoma.
    Zhang L; Li Z; Ma X; Yang W; Hao Y; Zhang L; Piao S
    Biochem Biophys Res Commun; 2024 May; 709():149842. PubMed ID: 38554601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current knowledge of ferroptosis in the pathogenesis and prognosis of oral squamous cell carcinoma.
    Zhou L; Wu Y; Ying Y; Ding Y
    Cell Signal; 2024 Jul; 119():111176. PubMed ID: 38636767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astaxanthin Synergizes with Ionizing Radiation (IR) in Oral Squamous Cell Carcinoma (OSCC).
    Du Y; Shuai Y; Liu Z; Li H; Yin Y
    Mol Biotechnol; 2024 May; 66(5):1220-1228. PubMed ID: 38103098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma.
    Hamad SH; Sellers RS; Wamsley N; Zolkind P; Schrank TP; Major MB; Weissman BE
    Cancer Res Commun; 2024 Feb; 4(2):487-495. PubMed ID: 38335300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARγ Antagonists Exhibit Antitumor Effects by Regulating Ferroptosis and Disulfidptosis.
    Zhang S; Wang Y; Gu J; Yang Y; Liang J; Wang Y; Ji N; Liu M; Zhang Y; Sun S; Chen Q; Li J
    Biomolecules; 2024 May; 14(5):. PubMed ID: 38786003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of Disulfiram and Copper-Cysteamine Nanoparticles for an Enhanced Antitumor Effect on Esophageal Cancer.
    Chang Y; Wu F; Pandey NK; Chudal L; Xing M; Zhang X; Nguyen L; Liu X; Liu JP; Chen W; Pan Z
    ACS Appl Bio Mater; 2020 Oct; 3(10):7147-7157. PubMed ID: 34179726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma.
    Wang Z; Tang S; Cai L; Wang Q; Pan D; Dong Y; Zhou H; Li J; Ji N; Zeng X; Zhou Y; Shen YQ; Chen Q
    Br J Cancer; 2024 May; 130(11):1744-1757. PubMed ID: 38582810
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Hou L; Liu Y; Liu W; Balash M; Zhang H; Zhang Y; Zhang H; Zhang Z
    Acta Pharm Sin B; 2021 Jul; 11(7):2016-2030. PubMed ID: 34386335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial.
    Jakola AS; Werlenius K; Mudaisi M; Hylin S; Kinhult S; Bartek J; Salvesen Ø; Carlsen SM; Strandéus M; Lindskog M; Löfgren D; Rydenhag B; Carstam L; Gulati S; Solheim O; Bartek J; Solheim T
    F1000Res; 2018; 7():1797. PubMed ID: 30647912
    [No Abstract]   [Full Text] [Related]  

  • 14. Turning anecdotal irradiation-induced anticancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells.
    Guo W; Jia L; Xie L; Kiang JG; Wang Y; Sun F; Lin Z; Wang E; Zhang Y; Huang P; Sun T; Zhang X; Bian Z; Tang T; Guo J; Ferrone S; Wang X
    Cell Death Dis; 2024 Apr; 15(4):298. PubMed ID: 38678042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized Sustained Release of Copper Enhances Antitumor Effects of Disulfiram in Head and Neck Cancer.
    Wang J; Li B; Cooper RC; Huang D; Yang H
    Biomacromolecules; 2024 May; 25(5):2770-2779. PubMed ID: 38687975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfiram Chelated With Copper Inhibits the Growth of Gastric Cancer Cells by Modulating Stress Response and Wnt/β-catenin Signaling.
    Wang L; Chai X; Wan R; Zhang H; Zhou C; Xiang L; Paul ME; Li Y
    Front Oncol; 2020; 10():595718. PubMed ID: 33409152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1α facilitates GSH synthesis to counteract oxidative stress in oral squamous cell carcinoma under glucose-deprivation.
    Ji Y; Zhang Z; Zhao X; Li Z; Hu X; Zhang M; Pan X; Wang X; Chen W
    Cancer Lett; 2024 May; 589():216833. PubMed ID: 38548217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting ferroptosis as a potential strategy to overcome the resistance of cisplatin in oral squamous cell carcinoma.
    Chen R; Zhu S; Zhao R; Liu W; Jin L; Ren X; He H
    Front Pharmacol; 2024; 15():1402514. PubMed ID: 38711989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quercetin induces ferroptosis by inactivating mTOR/S6KP70 pathway in oral squamous cell carcinoma.
    Zhu YW; Liu CL; Li XM; Shang Y
    Toxicol Mech Methods; 2024 May; ():1-7. PubMed ID: 38736312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Turning anecdotal irradiation-induced anti-cancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells.
    Wang X; Guo W; Jia L; Xie L; Kiang J; Wang Y; Wang F; Lin Z; Wang E; Zhang Y; Huang P; Sun T; Zhang X; Bian Z; Tang T; Guo J; Ferrone S
    Res Sq; 2023 Aug; ():. PubMed ID: 37645899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.